ABAGAT

Active ingredients

The drug ABAGAT contains one active pharmaceutical ingredient (API):

UNII 2E18WX195X - DABIGATRAN ETEXILATE

Dabigatran etexilate is a small molecule prodrug which does not exhibit any pharmacological activity. After oral administration, dabigatran etexilate is rapidly absorbed and converted to dabigatran by esterase-catalysed hydrolysis in plasma and in the liver. Dabigatran is a potent, competitive, reversible direct thrombin inhibitor and is the main active principle in plasma.

Read about Dabigatran

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Dabigatran etexilate
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors
Discover more medicines within B01AE07

Authorization and marketing

This brand name is authorized in the following countries: Malta

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
MT
Medicines Authority
Identifier(s): MA255/06101, MA255/06102, MA255/06103